FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138049072> ?p ?o ?g. }

• W3138049072 abstract "Objectives To conduct a systematic review and meta-analysis of the efficacy, comparative effectiveness, and harms of medications (both FDA approved and others) for adults with alcohol-use disorders, and to evaluate the evidence from primary care settings. Data sources PubMed®, Cochrane Library, PsycINFO®, CINAHL®, Embase®, U.S. Food and Drug Administration Web site, ClinicalTrials.gov , and World Health Organization International Clinical Trials Registry Platform (January 1, 1970, to October 11, 2013). Review methods Two investigators independently selected, extracted data from, and rated risk of bias of studies. We conducted meta-analyses using random-effects models. We graded strength of evidence (SOE) based on established guidance. Results We included 135 studies. Most patients met criteria for alcohol dependence; mean ages were in the 40s. Studies typically included psychosocial cointerventions; effect sizes reflect the added benefits of medications.For acamprosate and oral naltrexone (50 mg per day), numbers needed to treat (NNTs) to prevent 1 person from returning to any drinking were 12 and 20, respectively (moderate SOE); NNT to prevent 1 person from returning to heavy drinking was 12 for oral naltrexone (50 mg per day) (moderate SOE). Our meta-analyses of four head-to-head trials found no statistically significant difference between the two medications for consumption outcomes (moderate SOE). For injectable naltrexone, meta-analyses found no significant benefit for return to any or heavy drinking, but found a reduction in heavy drinking days (low SOE). Evidence from well-controlled trials does not support efficacy of disulfiram, except possibly for patients with excellent adherence. Among medications used off label, moderate evidence supports the efficacy of nalmefene and topiramate for improving some consumption outcomes, and limited evidence supports the efficacy of valproic acid. Evidence from primary care settings was scant. We found insufficient direct evidence to conclude whether medications for alcohol-use disorders are effective for improving health outcomes. Compared with placebo, patients treated with acamprosate had a higher risk of anxiety, diarrhea, and vomiting; those treated with naltrexone had a higher risk of dizziness, nausea, and vomiting. In head-to-head studies, the risks of headache and vomiting were slightly higher for naltrexone than for acamprosate. Individual trials of topiramate reported a significantly increased risk of paresthesias, anorexia, difficulty concentrating, dizziness, psychomotor slowing, and other adverse effects. Our meta-analyses for variation in naltrexone response related to OPRM1 polymorphisms found no statistically significant difference between A-allele homozygotes and those with at least one G allele, but confidence intervals were wide and additional studies are needed. Conclusions Acamprosate and oral naltrexone have the best evidence for improving alcohol consumption outcomes for patients with alcohol-use disorders. Head-to-head trials have not consistently established the superiority of one medication. Thus, other factors may guide medication choices, such as frequency of administration, potential adverse events, coexisting symptoms, and availability of treatments." @default.
• W3138049072 created "2021-03-29" @default.
• W3138049072 creator A5004993894 @default.
• W3138049072 creator A5008386224 @default.
• W3138049072 creator A5020378692 @default.
• W3138049072 creator A5043144907 @default.
• W3138049072 creator A5045337416 @default.
• W3138049072 creator A5068955067 @default.
• W3138049072 creator A5075147470 @default.
• W3138049072 creator A5076399844 @default.
• W3138049072 creator A5078220202 @default.
• W3138049072 creator A5086245154 @default.
• W3138049072 creator A5091360737 @default.
• W3138049072 date "2014-05-01" @default.
• W3138049072 modified "2023-09-27" @default.
• W3138049072 title "Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings [Internet]" @default.
• W3138049072 hasPublicationYear "2014" @default.
• W3138049072 type Work @default.
• W3138049072 sameAs 3138049072 @default.
• W3138049072 citedByCount "0" @default.
• W3138049072 crossrefType "journal-article" @default.
• W3138049072 hasAuthorship W3138049072A5004993894 @default.
• W3138049072 hasAuthorship W3138049072A5008386224 @default.
• W3138049072 hasAuthorship W3138049072A5020378692 @default.
• W3138049072 hasAuthorship W3138049072A5043144907 @default.
• W3138049072 hasAuthorship W3138049072A5045337416 @default.
• W3138049072 hasAuthorship W3138049072A5068955067 @default.
• W3138049072 hasAuthorship W3138049072A5075147470 @default.
• W3138049072 hasAuthorship W3138049072A5076399844 @default.
• W3138049072 hasAuthorship W3138049072A5078220202 @default.
• W3138049072 hasAuthorship W3138049072A5086245154 @default.
• W3138049072 hasAuthorship W3138049072A5091360737 @default.
• W3138049072 hasConcept C118552586 @default.
• W3138049072 hasConcept C126322002 @default.
• W3138049072 hasConcept C150966472 @default.
• W3138049072 hasConcept C168563851 @default.
• W3138049072 hasConcept C170493617 @default.
• W3138049072 hasConcept C17744445 @default.
• W3138049072 hasConcept C185592680 @default.
• W3138049072 hasConcept C199539241 @default.
• W3138049072 hasConcept C27415008 @default.
• W3138049072 hasConcept C2776478404 @default.
• W3138049072 hasConcept C2777972943 @default.
• W3138049072 hasConcept C2779436514 @default.
• W3138049072 hasConcept C2779473830 @default.
• W3138049072 hasConcept C2779549880 @default.
• W3138049072 hasConcept C2779992327 @default.
• W3138049072 hasConcept C2780687700 @default.
• W3138049072 hasConcept C2781063702 @default.
• W3138049072 hasConcept C2781066024 @default.
• W3138049072 hasConcept C2781145037 @default.
• W3138049072 hasConcept C55493867 @default.
• W3138049072 hasConcept C71924100 @default.
• W3138049072 hasConcept C95190672 @default.
• W3138049072 hasConceptScore W3138049072C118552586 @default.
• W3138049072 hasConceptScore W3138049072C126322002 @default.
• W3138049072 hasConceptScore W3138049072C150966472 @default.
• W3138049072 hasConceptScore W3138049072C168563851 @default.
• W3138049072 hasConceptScore W3138049072C170493617 @default.
• W3138049072 hasConceptScore W3138049072C17744445 @default.
• W3138049072 hasConceptScore W3138049072C185592680 @default.
• W3138049072 hasConceptScore W3138049072C199539241 @default.
• W3138049072 hasConceptScore W3138049072C27415008 @default.
• W3138049072 hasConceptScore W3138049072C2776478404 @default.
• W3138049072 hasConceptScore W3138049072C2777972943 @default.
• W3138049072 hasConceptScore W3138049072C2779436514 @default.
• W3138049072 hasConceptScore W3138049072C2779473830 @default.
• W3138049072 hasConceptScore W3138049072C2779549880 @default.
• W3138049072 hasConceptScore W3138049072C2779992327 @default.
• W3138049072 hasConceptScore W3138049072C2780687700 @default.
• W3138049072 hasConceptScore W3138049072C2781063702 @default.
• W3138049072 hasConceptScore W3138049072C2781066024 @default.
• W3138049072 hasConceptScore W3138049072C2781145037 @default.
• W3138049072 hasConceptScore W3138049072C55493867 @default.
• W3138049072 hasConceptScore W3138049072C71924100 @default.
• W3138049072 hasConceptScore W3138049072C95190672 @default.
• W3138049072 hasLocation W31380490721 @default.
• W3138049072 hasOpenAccess W3138049072 @default.
• W3138049072 hasPrimaryLocation W31380490721 @default.
• W3138049072 hasRelatedWork W1525349270 @default.
• W3138049072 hasRelatedWork W1822249615 @default.
• W3138049072 hasRelatedWork W1946712401 @default.
• W3138049072 hasRelatedWork W2126519871 @default.
• W3138049072 hasRelatedWork W2135168571 @default.
• W3138049072 hasRelatedWork W2165605153 @default.
• W3138049072 hasRelatedWork W2367997910 @default.
• W3138049072 hasRelatedWork W2519961995 @default.
• W3138049072 hasRelatedWork W2544885178 @default.
• W3138049072 hasRelatedWork W2751468029 @default.
• W3138049072 hasRelatedWork W2757054309 @default.
• W3138049072 hasRelatedWork W2811372873 @default.
• W3138049072 hasRelatedWork W2898472011 @default.
• W3138049072 hasRelatedWork W2902239813 @default.
• W3138049072 hasRelatedWork W2921501087 @default.
• W3138049072 hasRelatedWork W2980992731 @default.
• W3138049072 hasRelatedWork W3000659570 @default.
• W3138049072 hasRelatedWork W3007138583 @default.
• W3138049072 hasRelatedWork W3195953400 @default.
• W3138049072 hasRelatedWork W3081546334 @default.
• W3138049072 isParatext "false" @default.

• next